China SXT Pharmaceuticals (SXTC) Other Working Capital Changes (2018 - 2025)
Historic Other Working Capital Changes for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $65057.0.
- China SXT Pharmaceuticals' Other Working Capital Changes fell 6582.06% to $65057.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $65057.0, marking a year-over-year decrease of 6582.06%. This contributed to the annual value of $58627.0 for FY2025, which is 6875.98% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Other Working Capital Changes of $65057.0 as of Q3 2025, which was down 6582.06% from $58627.0 recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Other Working Capital Changes high stood at $480227.0 for Q3 2021, and its period low was $58627.0 during Q1 2025.
- Its 5-year average for Other Working Capital Changes is $194438.2, with a median of $134411.0 in 2022.
- In the last 5 years, China SXT Pharmaceuticals' Other Working Capital Changes surged by 35817.07% in 2021 and then crashed by 7721.68% in 2022.
- Over the past 5 years, China SXT Pharmaceuticals' Other Working Capital Changes (Quarter) stood at $480227.0 in 2021, then crashed by 77.22% to $109411.0 in 2022, then skyrocketed by 33.49% to $146049.0 in 2023, then skyrocketed by 30.33% to $190340.0 in 2024, then tumbled by 65.82% to $65057.0 in 2025.
- Its Other Working Capital Changes stands at $65057.0 for Q3 2025, versus $58627.0 for Q1 2025 and $190340.0 for Q3 2024.